152 related articles for article (PubMed ID: 15550926)
21. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Shi PA; De Angioletti M; Donahue RE; Notaro R; Luzzatto L; Dunbar CE
J Gene Med; 2004 Apr; 6(4):367-73. PubMed ID: 15079811
[TBL] [Abstract][Full Text] [Related]
22. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
23. Retinal cell type expression specificity of HIV-1-derived gene transfer vectors upon subretinal injection in the adult rat: influence of pseudotyping and promoter.
Bemelmans AP; Bonnel S; Houhou L; Dufour N; Nandrot E; Helmlinger D; Sarkis C; Abitbol M; Mallet J
J Gene Med; 2005 Oct; 7(10):1367-74. PubMed ID: 15966018
[TBL] [Abstract][Full Text] [Related]
24. Protection of MLV vector particles from human complement.
Breun S; Salmons B; Günzburg WH; Baumann JG
Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.
Kuate S; Stahl-Hennig C; Stoiber H; Nchinda G; Floto A; Franz M; Sauermann U; Bredl S; Deml L; Ignatius R; Norley S; Racz P; Tenner-Racz K; Steinman RM; Wagner R; Uberla K
Virology; 2006 Jul; 351(1):133-44. PubMed ID: 16616946
[TBL] [Abstract][Full Text] [Related]
26. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
27. [High efficiency gene transfer into breast cancer cells by pseudotyped retroviral vector].
Tang LL; Yu H
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):48-50. PubMed ID: 12536615
[TBL] [Abstract][Full Text] [Related]
28. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo.
Kaikkonen MU; Räty JK; Airenne KJ; Wirth T; Heikura T; Ylä-Herttuala S
Gene Ther; 2006 Feb; 13(4):304-12. PubMed ID: 16267571
[TBL] [Abstract][Full Text] [Related]
29. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system.
Hofmann C; Strauss M
Gene Ther; 1998 Apr; 5(4):531-6. PubMed ID: 9614578
[TBL] [Abstract][Full Text] [Related]
30. Transduction of human islets with the lentiviral vector.
Kobayashi N; Arata T; Okitsu T; Ikeda H; Kobayashi K; Kosaka Y; Narushima M; Tanaka N; Lakey JR
Transplant Proc; 2004 Sep; 36(7):2203-4. PubMed ID: 15518800
[TBL] [Abstract][Full Text] [Related]
31. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.
Diaz RM; Bateman A; Emiliusen L; Fielding A; Trono D; Russell SJ; Vile RG
Gene Ther; 2000 Oct; 7(19):1656-63. PubMed ID: 11083474
[TBL] [Abstract][Full Text] [Related]
32. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of double-expression retroviral vector using complement regulatory factor gene.
Hayashi S; Emi N; Okada H; Yokoyama I; Takagi H
J Surg Res; 1998 Jul; 78(1):64-7. PubMed ID: 9733620
[TBL] [Abstract][Full Text] [Related]
34. Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus.
Ohishi M; Shioda T; Sakuragi J
Virology; 2007 May; 362(1):131-8. PubMed ID: 17258261
[TBL] [Abstract][Full Text] [Related]
35. HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys.
Jimenez DF; Lee CI; O'Shea CE; Kohn DB; Tarantal AF
Gene Ther; 2005 May; 12(10):821-30. PubMed ID: 15815706
[TBL] [Abstract][Full Text] [Related]
36. Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1.
Hofmann C; Hüser A; Lehnert W; Strauss M
Biol Chem; 1999 Mar; 380(3):393-5. PubMed ID: 10223343
[TBL] [Abstract][Full Text] [Related]
37. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.
Simmons A; Whitehead RP; Kolokoltsov AA; Davey RA
Virol J; 2006 Feb; 3():8. PubMed ID: 16507098
[TBL] [Abstract][Full Text] [Related]
38. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum.
Croyle MA; Callahan SM; Auricchio A; Schumer G; Linse KD; Wilson JM; Brunner LJ; Kobinger GP
J Virol; 2004 Jan; 78(2):912-21. PubMed ID: 14694122
[TBL] [Abstract][Full Text] [Related]
39. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
Kumar M; Bradow BP; Zimmerberg J
Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
[TBL] [Abstract][Full Text] [Related]
40. Membrane complement regulatory proteins.
Kim DD; Song WC
Clin Immunol; 2006; 118(2-3):127-36. PubMed ID: 16338172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
